Searchable abstracts of presentations at key conferences in endocrinology

ea0020s3.3 | Genetics in neuroendocrinology | ECE2009

The GPR54 gene mutations as a cause for hypogonadotropic hypogonadism

Latronico Ana

The identification of naturally occurring genetic mutations has provided unique insight into the current knowledge of the human hypothalamic–pituitary–gonadal axis. In the last 5 years, several loss-of-function mutations in the G-protein coupled receptor 54 (GPR54) gene have been shown to cause isolated hypogonadotropic hypogonadism. Although these mutations are not a common cause of hypogonadotropic hypogonadism, patients bearing mutations are critical to explore ge...

ea0063p1146 | Reproductive Endocrinology 2 | ECE2019

Recurrent reversal of male congenital hypogonadotropic hypogonadism and atypical fertility: A case report.

Renck Alessandra , Rocha Michelle , Amato Lorena , Schnoll Caroline , Sales Priscila , Latronico Ana , Mendonca Berenice , Costa Elaine , Silveira Leticia

Abstract: Congenital hypogonadotropic hypogonadism (CHH) is characterized by isolated GnRH deficiency in the absence of central anatomical causes. Classically considered to be a permanent disorder, CHH reversal has been reported in up to 15% of cases. However, reversal may not always be life-long, as hypogonadism relapse can occur in a subset of patients. Criteria for reversal normalization of circulating sex steroids, and spontaneous fertility. We report a 26-yrs-old man, who...

ea0099ep183 | Endocrine-Related Cancer | ECE2024

Clinical and pathological predictors of death for adrenocortical carcinoma

Pato Eduardo , Srougi Victor , Zerbini Claudia , Ledesma Felipe , Tanno Fabio , Almeida Madson , Nahas William , Claudia Latronico Ana , Mendonca Berenice , Chambo Jose , Candida Fragoso Maria

Adrenocortical Carcinoma (ACC) is a rare and lethal disease with a poor prognosis. This study aims to share our 41-year experience as a referral center, focusing on identifying risk factors associated with ACC mortality. Our retrospective analysis included a cohort of 150 adult patients with ACC in all stage categories, treated between 1981 and 2022. Tumor hormonal hypersecretion was observed in 78.6% of the patients, and the median age of diagnosis was 40 years. The majority ...

ea0086p343 | Neuroendocrinology and Pituitary | SFEBES2022

Variants in Methyl-CpG-binding protein 2 (MECP2) are associated with X-Linked Central Precocious Puberty

E Read Jordan , Pinheiro-Machado Canton Ana , Tinano Flavia , Guasti Leonardo , Ribeiro Montenegro Luciana , Ryan Fiona , Shears Deborah , Paganoni Alyssa , Korbonits Marta , Jorge Alexander , David Alessia , Bilharinho Mendonca Berenice , Nahime Brito Vinicius , Claudia Latronico Ana , Howard Sasha R

Whilst several key genetic contributors to the phenotype of central precocious puberty (CPP) have been recognized, many familial cases remain without a clear genetic aetiology. Methyl-CpG-binding protein 2 (MECP2) is a chromatin-associated transcriptional regulator, which plays an essential role in neuronal maturation. It is encoded by the MECP2 gene, located at chromosome Xq28, which is highly expressed in brain tissues. Loss-of-function mutations in MECP2 are usually associa...

ea0099ep186 | Adrenal and Cardiovascular Endocrinology | ECE2024

Undetermined masses in adrenal topography: experience of a compound by a tertiary health center

Weber kuhn Aliny , Srougi Victor , Brondani Vania , Tanno Fabio , de Freitas Ricardo , Coelho Fernando , Pereira Maria , Almeida Madson , Claudia Latronico Ana , Chambo Jose , Mendonca Berenice , Candida Barisson Villares Fragoso Maria

Introduction: Masses in adrenal topography have been diagnosed frequently due to more available access to radiological imaging. Adrenal incidentalomas occur around 5% to 7% of patients undergoing abdominal imaging mainly over 50 years of age. The HCFMUSP is a complex tertiary center, a national reference to adrenal disorders and since 2006 around 300 adrenalectomies were performed; 8% of them corresponded to undetermined masses in adrenal topography.Obje...

ea0063gp62 | Reproductive Axis | ECE2019

Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, Mkrn3

Castellano Juan M , Heras Violeta , Sangiao-Alvarellos Susana , Manfredi-Lozano Maria , Sanchez-Tapia Maria J , Ruiz-Pino Francisco , Roa Juan , Lara-Chica Maribel , Morrugares-Carmona Rosario , Abreu Ana P , Belsham Denise , Vazquez Maria J , Calzado Marco A , Pinilla Leonor , Gaytan Francisco , Latronico Ana C , Kaiser Ursula B , Tena-Sempere Manuel

Mkrn3, the maternally imprinted gene encoding the makorin RING-finger protein-3, has recently emerged as putative pubertal repressor, as evidenced by central precocity caused by MKRN3 mutations in humans; yet, the molecular underpinnings of this key regulatory action remain largely unexplored. We report herein that the microRNA, miR-30, with three binding sites in a highly conserved region of its 3’-untranslated region (UTR), operates as repressor of Mkrn3 to control pube...

ea0099rc11.2 | Rapid Communications 11: Adrenal and Cardiovascular Endocrinology | Part II | ECE2024

Contralateral suppression in adrenal venous sampling predicts clinical and biochemical outcome in primary aldosteronism

Okubo Jessica , Frudit Paula , Cavalcante Aline , Maciel Ana Alice , Castanheira Thais , Pilan Bruna , Fagundes Gustavo , Queiroz Nara , Stumpf Matheo , Souza Victor , Kawahara Eduardo , Goldbaum Tatiana , Pereira Maria Adelaide , Calsavara Vinicius , Drager Luciano , Fragoso Maria Candida , Latronico Ana Claudia , Mendonca Berenice , Carnevale Francisco , Almeida Madson

Context: The role for hormone parameters at adrenal venous sampling (AVS) in predicting clinical and biochemical outcome remains controversial.Objective: To investigate the impact of hormone parameters at AVS under cosyntropin stimulation on lateralization and on complete biochemical and clinical outcome.Methods: We retrospectively evaluated 168 sequential AVS under cosyntropin infusion. Bilateral successful cannulation rate was 83...